Dilution profile // every instrument, one screen, from SEC filings

Akso Health Group (AHG)

CIK 1702318 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed sub-ratings (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHF-3/A on file 2025-05-22
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno current share count to divide by
= warrant shares outstanding divided by current shares outstanding
not rated: the newest single-total cover-page count is as of 2025-03-31
Historical dilution
NOT COMPUTEDnewest single-total cover-page count is as of 2025-03-31
= share count now vs 3 years ago
not rated: the company has filed periodic reports since (newest: 20-F filed 2026-07-23) with no single-total cover-page count in SEC's companyfacts, which omits counts filed per share class
Cash need
HIGH~0.2 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2018-03-312025-03-31

Newest single-total count on a cover page: 1.66B as of Mar 31, 2025 (20-F). Not used as today’s count, because the company has filed periodic reports since (newest: 20-F filed 2026-07-23) with no single-total cover-page count in SEC's companyfacts, which omits counts filed per share class.

⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2025-03-31
HowKept on the chart with its date. No estimate, rating or current-share figure on this page is built on it.
Open the source document →

Cash runway

~0 months of cash left

critical · burning $3.2M / quarter

Full breakdown: cash runway tool

Warrants

Warrants outstanding: 6.3M underlying shares, as reported Sep 30, 2023 (6-K).

Reported exercise price: $0.461 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $1.12B as of Mar 31, 2025.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

EFFECTIVEJun 6, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 22, 2025F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
REGISTEREDJan 6, 2025F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
WITHDRAWNNov 26, 2024Registration withdrawnRW →
REGISTEREDNov 26, 2024F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
REGISTEREDNov 21, 2024F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
EXECUTEDMar 7, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
REGISTEREDFeb 23, 2024F-3 registration — capacity to sell shares, not a sale yetF-3 →
UPDATEDec 17, 2021Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEFeb 25, 2021SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDFeb 23, 2021F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
REGISTEREDJan 26, 2021F-3 registration — capacity to sell shares, not a sale yetF-3 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full AHG workspace

Free to use. No account, no card.